| Identification | |
| Name: | 2-Naphthacenecarboxylicacid, 4-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-,hydrochloride, (2S-cis)- (9CI) |
| Synonyms: | NSC235816 |
| CAS: | 58199-96-5 |
| Molecular Formula: | C26H27 N O11 . Cl H |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C26H27NO11/c1-9-20(28)12(27)6-15(37-9)38-14-8-26(35,25(33)34)7-11-17(14)24(32)19-18(22(11)30)21(29)10-4-3-5-13(36-2)16(10)23(19)31/h3-5,9,12,14-15,20,28,30,32,35H,6-8,27H2,1-2H3,(H,33,34) |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 446.9°C |
| Boiling Point: | 815.3°C at 760 mmHg |
| Density: | 1.65g/cm3 |
| Refractive index: | 1.722 |
| Specification: | Red Solid usageEng:Doxorubicin analog. Antitumor drug |
| Flash Point: | 446.9°C |
| Storage Temperature: | Amber Vial, -20?C Freezer |
| Usage: | Doxorubicin analog. Antitumor drug |
| Safety Data | |
 |
|
